Selva Therapeutics
制药业
San Diego，CA 262 位关注者
Selva is developing therapeutic drugs for coronaviruses (SARS-CoV-2), filoviruses (Ebola) and Chagas Disease.
关于我们
Selva Therapeutics is a privately held biotechnology company dedicated to the development of therapeutics for infectious diseases. The company’s lead drug candidate, SLV213, is an orally available small molecule novel antiviral therapy with activity against a broad range of viruses that threaten global health, including SARS-CoV-2, the virus causing COVID-19. In addition, SLV213 has activity against Ebola and Nipah viruses and has completed preclinical development as a potential therapy against Chagas disease. Selva is headquartered in San Diego.
- 网站
-
https://www.selvarx.com
Selva Therapeutics的外部链接
- 所属行业
- 制药业
- 规模
- 2-10 人
- 总部
- San Diego，CA
- 类型
- 私人持股
地点
-
主要
获取路线
US，CA，San Diego